Literature DB >> 26333808

Heterochromatin protein HP1γ promotes colorectal cancer progression and is regulated by miR-30a.

Ming Liu1, Feifei Huang1, Dan Zhang2, Junyi Ju1, Xiao-Bin Wu2, Ying Wang1, Yadong Wang1, Yupeng Wu1, Min Nie1, Zhuchen Li1, Chi Ma1, Xi Chen1, Jin-Yong Zhou2, Renxiang Tan1, Bo-Lin Yang2, Ke Zen1, Chen-Yu Zhang1, Yu-Gen Chen3, Quan Zhao4.   

Abstract

Colorectal cancer pathogenesis remains incompletely understood. Here, we report that the heterochromatin protein HP1γ is upregulated commonly in human colorectal cancer, where it promotes cell proliferation in vitro and in vivo. Gene-expression and promoter-binding experiments demonstrated that HP1γ directly regulated CDKN1A (p21(Waf1/Cip1)) in a manner associated with methylation of histone H3K9 on its promoter. We identified miR-30a as a tumor-suppressive microRNA that targets HP1γ in vitro and in vivo to specifically suppress the growth of colorectal cancer in mouse xenograft models. MiR-30a was widely downregulated in primary human colorectal cancer tissues, where its expression correlated inversely with high levels of HP1γ protein. Our results identify a new miR-30a/HP1γ/p21 regulatory axis controlling colorectal cancer development, which may offer prognostic and therapeutic opportunities. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26333808     DOI: 10.1158/0008-5472.CAN-14-3735

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.

Authors:  C Chang; J Liu; W He; M Qu; X Huang; Y Deng; L Shen; X Zhao; H Guo; J Jiang; X Y Fu; R Huang; D Zhang; J Yan
Journal:  Oncogene       Date:  2017-10-02       Impact factor: 9.867

2.  MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.

Authors:  Hongxing Shen; Chuan Xing; Kaisa Cui; Yunxiao Li; Jinxiang Zhang; Runlei Du; Xiaodong Zhang; Youjun Li
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

3.  MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor.

Authors:  Y C Liu; Y R Park; S L Kim; S T Lee; S W Kim
Journal:  Dig Dis Sci       Date:  2017-09-20       Impact factor: 3.199

4.  Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.

Authors:  Alberto Valdés; Virginia García-Cañas; Konstantin A Artemenko; Carolina Simó; Jonas Bergquist; Alejandro Cifuentes
Journal:  Mol Cell Proteomics       Date:  2016-11-10       Impact factor: 5.911

5.  CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.

Authors:  Wen Peng; Shuang Shi; Jiacheng Zhong; Hanghua Liang; Jianbin Hou; Xiaosong Hu; Feng Wang; Jiayi Zhang; Shengjun Geng; Xiaochuan Sun; Dong Zhong; Hongjuan Cui
Journal:  Oncogene       Date:  2022-04-22       Impact factor: 9.867

6.  Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma.

Authors:  Qian Li; Lei Fu; Daoyuan Wu; Jufeng Wang
Journal:  J Gastrointest Oncol       Date:  2021-10

7.  HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.

Authors:  Hunain Alam; Na Li; Shilpa S Dhar; Sarah J Wu; Jie Lv; Kaifu Chen; Elsa R Flores; Laura Baseler; Min Gyu Lee
Journal:  Cancer Res       Date:  2018-05-15       Impact factor: 12.701

8.  microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2.

Authors:  Jimin Min; Tae-Su Han; Yoojin Sohn; Takahiro Shimizu; Boram Choi; Seong-Woo Bae; Keun Hur; Seong-Ho Kong; Yun-Suhk Suh; Hyuk-Joon Lee; Jang-Seong Kim; Jeong-Ki Min; Woo-Ho Kim; V Narry Kim; Eunyoung Choi; James R Goldenring; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  2020-02-28       Impact factor: 7.370

Review 9.  Heterochromatin protein 1 (HP1): interactions with itself and chromatin components.

Authors:  Amarjeet Kumar; Hidetoshi Kono
Journal:  Biophys Rev       Date:  2020-03-06

10.  Evaluation of the prognostic value of CBXs in gastric cancer patients.

Authors:  Mengya He; Limin Yue; Haiyan Wang; Feiyan Yu; Mingyang Yu; Peng Ni; Ke Zhang; Shuaiyin Chen; Guangcai Duan; Rongguang Zhang
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.